News Conference News TCT 2018 ReCre8: Physician-Led Study Shows Noninferiority of Polymer-Free Stent Compared With Permanent-Polymer ZES at 1 Year Yael L. Maxwell September 22, 2018
Presentation TCT 2018 Patient-Centered Engagement in Trials: Case Example - ADAPTABLE Presenter: John C Laschinger, J. Dawn Abbott, Lori M Ashby, Robert A. Byrne, David A. Cox, Mona Fiuzat, Christopher O'Connor, John A. Spertus, Susan Strong September 22, 2018
Presentation TCT 2018 FDAs Patient Engagement Initiatives: How FDA Can Incorporate Patient Centered and Patient Reported Outcomes in Regulatory Decision-Making Presenter: John C Laschinger September 22, 2018
Presentation TCT 2018 The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe Presenter: Marek Grygier September 22, 2018
Presentation TCT 2018 The Overview of Clinical Trials and Current Target Population for LAAC Closure Presenter: Shephal Doshi September 22, 2018
Presentation TCT 2018 How the Best-CLI Trial Will Change Clinical Practice Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Matthew T. Menard September 22, 2018
Presentation TCT 2018 Clinical Trials for Short DAPT: FDA Perspective Presenter: Christopher J Popma September 22, 2018
News Opinion Editor's Corner TCT 2018 TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents Shelley Wood September 22, 2018
Presentation TCT 2018 Status Update of the TAVR UNLOAD Trial Moderate AS Patients with Reduced Ejection Fraction and Heart Failure Presenter: Allan Schwartz, Stephan Windecker, Joost Daemen September 22, 2018
Presentation TCT 2018 Rationale for Treating SASS and Update of the EARLY-TAVR Trial Presenter: Allan Schwartz September 22, 2018
Presentation TCT 2018 The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials Presenter: Allan Schwartz, Stephan Windecker, Jeffrey J. Popma September 22, 2018
Presentation TCT 2018 Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials Presenter: Alexandra J. Lansky, Axel Linke, Tamim Nazif September 22, 2018
Presentation TCT 2018 IABP in Cardiogenic Shock: Reconciling Clinical Trial Results and Guidelines With Real-World Experience (With Practical-use Recommendations) Presenter: Cindy L. Grines, E. Magnus Ohman, Richard Smalling September 22, 2018
Presentation TCT 2018 Most Important Clinical Trials in Vascular Medicine and Intervention in the Past 10 Years Presenter: Jay S. Giri, Sahil A. Parikh September 22, 2018
News Conference News TCT 2018 EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis Michael O'Riordan September 21, 2018
News Opinion Off Script TCT 2018 Off Script: Welcome to the 30th TCT 2018 in Sunny San Diego Kwan S. Lee September 21, 2018
Presentation TCT 2018 TCT-120: Long-term Outcomes in Women and Men Following Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis from 21 Randomized Trials Presenter: Michael A. Kutcher, Tullio Palmerini, Ioanna Kosmidou September 21, 2018
Presentation TCT 2018 TCT-112: Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Event in the Global Leaders Trial Presenter: George D. Dangas, Germano Di Sciascio, Patrick W. Serruys September 21, 2018